Crossmark

Transarterial chemoembolization combined with tyrosine kinase inhibitors and/or immune checkpoint inhibitors induced hypothyroidism is associated with improved overall survival in hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1007/s00262-025-04073-5

Published Online: 2025-05-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Shengyuan

Zheng, Ruipeng

Sun, Chenghao

Sa, Ri
Funding

Funding for this research was provided by:

the National Natural Science Foundation of China (82202204)
License Information

Text and Data Mining valid from 2025-05-24

Version of Record valid from 2025-05-24
More Information

Article History

Received: 4 April 2025

Accepted: 30 April 2025

First Online: 24 May 2025

Declarations

:

: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

: This study was approved by the Ethics Committee of the First Hospital of Jilin University (2024–686).

Document is current

Any future updates will be listed below